Human papillomavirus is detected in transitional cell carcinoma arising in renal transplant recipients

Pathology

Volumn 41, Issue 3, 2009, Pages 245-247

  Husain, Ehab ^a   Prowse, David M ^b   Ktori, Elena ^b   Shaikh, Taufiq ^a   Yaqoob, Magdi ^a   Junaid, Islam ^a   Baithun, Suhail ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Carcinogenesis; HPV; Immunosuppression; Renal transplant; TCC

Indexed keywords

BETA GLOBIN; GENOMIC DNA; VIRUS DNA;

ARTICLE; BIOTINYLATION; CONTROLLED STUDY; DNA EXTRACTION; GENE AMPLIFICATION; GENOTYPE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; VIRUS DETECTION; WART VIRUS; BLADDER TUMOR; GENETICS; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; VIROLOGY; VIRUS INFECTION;

CARCINOMA, TRANSITIONAL CELL; DNA, VIRAL; HUMANS; KIDNEY TRANSPLANTATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS;

EID: 68849084945     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020902756303     Document Type: Article

References (27)

1. Leppert JT, Shvarts O, Kawaoka K, et al. Prevention of bladder cancer: a review. Eur Urol 2006; 49: 226-234
2. Kirkali Z, Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 2003; 47: 155-169 (Pubitemid 36945314)
3. Kao YL, Ou YC, Yang CR, et al. Transitional cell carcinoma in renal transplant recipients. World J Surg 2003; 27: 912-916
4. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006; 24 (Suppl 3): S11-25.
5. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis 2006; 6: 21-31.
6. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001; 25: 884-891
7. Van Der Graaf Y, Molijn A, Doornewaard H, et al. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 2002; 156: 158-164
8. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19
9. Sur M, Cooper K, Allard U. Investigation of human papillomavirus in transitional cell carcinomas of the urinary bladder in South Africa. Pathology 2001; 33: 17-20.
10. Kamel D, Paakko P, Pollanen R, et al. Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder. Apmis 1995; 103: 331-338
11. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and Identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508-2517
12. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006; 110: 525-541
13. Saltzstein DR, Orihuela E, Kocurek JN, et al. Failure of the polymerase chain reaction (PCR) to detect human papilloma virus (HPV) in transitional cell carcinoma of the bladder. Anticancer Res 1993; 13: 423-425
14. Aynaud O, Tranbaloc P, Orth G. Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. J Urol 1998; 159: 86-9; discussion 90. (Pubitemid 127739878)
15. Sano T, Sakurai S, Fukuda T, et al. Unsuccessful e.ort to detect human papillomavirus DNA in urinary bladder cancers by the polymerase chain reaction and in situ hybridization. Pathol Int 1995; 45: 506-512
16. Youshya S, Purdie K, Breuer J, et al. Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J Clin Pathol 2005; 58: 207-210
17. Mvula M, Iwasaka T, Iguchi A, et al. Do human papillomaviruses have a role in the pathogenesis of bladder carcinoma? J Urol 1996; 155: 471-474
18. LaRue H, Simoneau M, Fradet Y. Human papillomavirus in transitional cell carcinoma of the urinary bladder. Clin Cancer Res 1995; 1: 435-440
19. Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001; 159: 1211-1218
20. Koskinen WJ, Chen RW, Leivo I, et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 2003; 107: 401-406
21. Lopez-Beltran A, Escudero AL, Vicioso L, et al. Human papillomavirus DNA as a factor determining the survival of bladder cancer patients. Br J Cancer 1996; 73: 124-127
22. Smetana Z, Keller T, Leventon-Kriss S, et al. Presence of human papilloma virus in transitional cell carcinoma in Jewish population in Israel. Cell Mol Biol (Noisy-le-grand) 1995; 41: 1017-1023
23. Agliano AM, Gradilone A, Gazzaniga P, et al. High frequency of human papillomavirus detection in urinary bladder cancer. Urol Int 1994; 53: 125-129
24. Querci della Rovere G, Oliver RT, McCance DJ, et al. Development of bladder tumour containing HPV type 11 DNA after renal transplantation. Br J Urol 1988; 62: 36-38
25. Kitamura T, Yogo Y, Ueki T, et al. Presence of human papillomavirus type 16 genome in bladder carcinoma in situ of a patient with mild immunode.ciency. Cancer Res 1988; 48: 7207-7211
26. Gaya SB, Rees AJ, Lechler RI, et al.Malignant disease in patients with long-term renal transplants. Transplantation 1995; 59: 1705-1709
27. Tremblay F, Fernandes M, Habbab F, et al. Malignancy after renal transplantation: incidence and role of type of immunosuppression. Ann Surg Oncol 2002; 9: 785-788